Jan 19, 2026
When people are diagnosed with small intestinal bacterial overgrowth (SIBO), it’s natural to assume that SIBO itself is the main problem. However, SIBO is a secondary condition, meaning it develops because another disease or disruption has changed how the digestive system normally works. Understanding this distinction helps explain why SIBO often returns and why treatment sometimes needs to go beyond reducing bacteria alone.
What Does “Secondary Condition” Mean?
A primary disease is the main condition affecting the body. It is the starting point of a problem.
A secondary condition develops as a consequence of that primary disease. It reflects downstream effects rather than an independent cause.
SIBO is secondary because it arises when the gut’s natural defenses against bacterial overgrowth are compromised. These defenses include:
Normal gut movement (motility)
Stomach acid and digestive enzymes
The immune system
Physical barriers, such as the ileocecal valve
When one or more of these systems stops working properly, bacteria are more likely to accumulate in the small intestine.
The Most Common Ways Primary Conditions Lead to SIBO
Disrupted Gut Motility
Impaired gut movement is the most common driver of SIBO. When food and bacteria are not cleared efficiently, they linger and multiply.
Conditions that affect nerves, muscles, or coordination in the gut can slow motility, including autoimmune, neurological, metabolic, and hormonal disorders. In these cases, SIBO develops because the gut can no longer “self-clean” effectively.
Structural or Anatomical Changes
Physical changes to the digestive tract can also create areas where food and bacteria collect.
Examples include digestive surgeries that alter normal anatomy, loss of the ileocecal valve, or inflammatory bowel disease with strictures or scar tissue. These changes remove mechanical barriers that normally help keep bacteria in the right place and/or moving smoothly through the digestive system.
Weakened Chemical or Immune Defenses
The gut relies on chemical and immune defenses to control bacteria. SIBO risk increases when stomach acid is reduced, digestive juices or bile acids are impaired, or immune signaling in the gut is altered. When the gut environment changes, bacteria that would normally be controlled can survive and overgrow.
The Cycle of SIBO
Once SIBO develops as a secondary condition, it often worsens the underlying problem.
Bacterial overgrowth can interfere with nutrient absorption, increase inflammation, disrupt bile acids, and increase intestinal permeability. These effects can aggravate symptoms of the primary disease, creating a feedback loop where SIBO and the underlying condition reinforce each other.
This is one reason SIBO can be difficult to treat if the root cause is not also addressed.
The Takeaway
Understanding SIBO as a secondary condition is key to understanding why a SIBO diagnosis cannot identify the root cause of symptoms. For many people, symptoms may continue to occur until the primary condition is identified and addressed.
Key References
Barlow, G. M., & Pimentel, M. (2025). Modern concepts of small intestinal bacterial overgrowth. Current Opinion in Gastroenterology, 41(6), 399–408. https://doi.org/10.1097/MOG.0000000000001135
Birg, A., & Lin, H. C. (2025). The role of bacteria-derived hydrogen sulfide in multiple axes of disease. International Journal of Molecular Sciences, 26, 3340. https://doi.org/10.3390/ijms26073340
Cedars-Sinai. (2025, April 4). New Cedars-Sinai study shows how specialized diet can improve gut disorders [Press release].
Goździewska, M., Łyszczarz, A., Kaczoruk, M., & Kolarzyk, E. (2024). Relationship between periodontal diseases and non-specific inflammatory bowel diseases – An overview. Part I. Annals of Agricultural and Environmental Medicine, 31(1), 1–7. https://doi.org/10.26444/aaem/185764
Goździewska, M., Łyszczarz, A., Kaczoruk, M., & Kolarzyk, E. (2024). Relationship between SIBO and other bowel diseases and a common eating pattern for them. Part III. Annals of Agricultural and Environmental Medicine, 31(3), 322–328. https://doi.org/10.26444/aaem/193103
Li, X., Feng, X., Jiang, Z., & Jiang, Z. (2021). Association of small intestinal bacterial overgrowth with Parkinson’s disease: A systematic review and meta-analysis. Gut Pathogens, 13(25). https://doi.org/10.1186/s13099-021-00420-w
Losurdo, G., et al. (2020). The influence of small intestinal bacterial overgrowth in digestive and extra-intestinal disorders. International Journal of Molecular Sciences, 21, 3531. https://doi.org/10.3390/ijms21103531
Roszkowska, P., et al. (2024). Small intestinal bacterial overgrowth (SIBO) and twelve groups of related diseases—Current state of knowledge. Biomedicines, 12, 1030. https://doi.org/10.3390/biomedicines12051030
Sroka, N., et al. (2023). Show me what you have inside—The complex interplay between SIBO and multiple medical conditions—A systematic review. Nutrients, 15, 90. https://doi.org/10.3390/nu15010090
Takakura, W., & Pimentel, M. (2020). Small intestinal bacterial overgrowth and irritable bowel syndrome – An update. Frontiers in Psychiatry, 11, 664. https://doi.org/10.3389/fpsyt.2020.00664

